COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis.

John, Binu V; Bastaich, Dustin R; Ferreira, Raphaella D; Doshi, Akash; Taddei, Tamar H; Kaplan, David E; Spector, Seth; Deng, Yangyang; Dahman, Bassam

John, Binu V; Bastaich, Dustin R; Ferreira, Raphaella D; Doshi, Akash; Taddei, Tamar H; Kaplan, David E; Spector, Seth; Deng, Yangyang; Dahman, Bassam.

John BV; Gastroenterology and Hepatology, University of Miami, Miami, Florida, USA binu.john@gmail.com.
Bastaich DR; Gastroenterology and Hepatology, Miami VA Healthcare System, Miami, Florida, USA.
Ferreira RD; Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, Virginia, USA.
Doshi A; Gastroenterology and Hepatology, Miami VA Healthcare System, Miami, Florida, USA.
Taddei TH; Miller School of Medicine, University of Miami, Miami, Florida, USA.
Kaplan DE; Medicine, VA Connecticut Health System West Haven Campus, West Haven, Connecticut, USA.
Spector S; Gastroenterology and Hepatology, Hospital of the Inversity of Pennsylvania, Philadelphia, Pennsylvania, USA.
Deng Y; Department of Surgery, University of Miami, Coral Gables, Florida, USA.
Dahman B; Department of Surgery, Bruce W Carter Department of Veterans Affairs Medical Center, Miami, Florida, USA.

Gut ; 2022 Sep 05.

Article in English | MEDLINE | ID: covidwho-2020115

Keywords

CIRRHOSIS; COVID-19

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Language: English Year: 2022 Document Type: Article Affiliation country: Gutjnl-2022-327799

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google